- Home
- AUPH vs SHO Comparison
AUPH vs SHO Comparison
Compare AUPH & SHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- SHO
- Stock Information
- Founded
- AUPH 1993
- SHO 1995
- Country
- AUPH Canada
- SHO United States
- Employees
- AUPH N/A
- SHO N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- SHO Hotels/Resorts
- Sector
- AUPH Health Care
- SHO Consumer Discretionary
- Exchange
- AUPH Nasdaq
- SHO Nasdaq
- Market Cap
- AUPH 1.6B
- SHO 1.8B
- IPO Year
- AUPH 1999
- SHO 1995
- Fundamental
- Price
- AUPH $13.17
- SHO $9.04
- Analyst Decision
- AUPH Strong Buy
- SHO Hold
- Analyst Count
- AUPH 2
- SHO 7
- Target Price
- AUPH $13.00
- SHO $9.21
- AVG Volume (30 Days)
- AUPH 1.3M
- SHO 1.0M
- Earning Date
- AUPH 11-04-2025
- SHO 11-07-2025
- Dividend Yield
- AUPH N/A
- SHO 3.98%
- EPS Growth
- AUPH N/A
- SHO N/A
- EPS
- AUPH 0.42
- SHO 0.02
- Revenue
- AUPH $260,111,000.00
- SHO $934,999,000.00
- Revenue This Year
- AUPH $17.33
- SHO $5.78
- Revenue Next Year
- AUPH $14.31
- SHO $5.62
- P/E Ratio
- AUPH $31.33
- SHO $475.89
- Revenue Growth
- AUPH 25.59
- SHO 0.37
- 52 Week Low
- AUPH $6.55
- SHO $7.45
- 52 Week High
- AUPH $13.54
- SHO $12.41
- Technical
- Relative Strength Index (RSI)
- AUPH 65.73
- SHO 45.16
- Support Level
- AUPH $11.96
- SHO $8.70
- Resistance Level
- AUPH $12.70
- SHO $9.29
- Average True Range (ATR)
- AUPH 0.47
- SHO 0.22
- MACD
- AUPH 0.17
- SHO -0.02
- Stochastic Oscillator
- AUPH 85.96
- SHO 46.58
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.
Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in Califiornia which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its hotel ownership segment.